2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)-
- CAS No.
- 2639638-66-5
- Chemical Name:
- 2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)-
- Synonyms
- BAY-069, 10 mM in DMSO;2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)-
- CBNumber:
- CB012246326
- Molecular Formula:
- C22H14ClF3N2O3
- Molecular Weight:
- 446.81
- MDL Number:
- MOL File:
- 2639638-66-5.mol
2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)- Chemical Properties,Uses,Production
Description
BAY-069 is a BCAT1/2 Inhibitor and Chemical Probe. BAY-069 displays high cellular activity and very good selectivity. BAY-069 displays high cellular activity. Its overall in vivo pharmacokinetic profile and its selectivity in various in vitro panels suggest that BAY-069 is suitable for in vivo experiments. Note: BAY-069 is the more active atropisomer with M-helical with IC50 of 31 nM (BCAT1), while the other atropisomer has only micromolar activity. BAY-771 is the negative control for BAY-609.
Uses
BAY-069 is a potent branched-chain amino acid transaminases 1 (BCAT1) and BCAT2 inhibitor with IC50 values of 31 nM and 153 nM, respectively. BAY-069 also can be used as a chemical probe. BAY-069 can be used tor research anticancer[1].
in vivo
BAY-069 exhibits high metabolic stability after incubation with human liver microsomes (CLblood = 0.11 L/h/kg) and moderate metabolic stability after incubation with rat hepatocytes (CLblood = 1.8 L/h/kg); shows high permeability through Caco-2 cell monolayers with no hint of efflux[1].
BAY-069 (0.3 mg/kg for i.v.; 0.6 mg/kg for p.o.; single dosage) exhibits a favorable pharmacokinetic profile after i.v. dosing with low blood clearance (CLblood), moderate volume of distribution at steady state (Vss), and intermediate terminal half-life (t1/2).
Animal Model: | Male Wistar rats[1] | ||||||||||||
Dosage: | 0.3 mg/kg for i.v.; 0.6 mg/kg for p.o. | ||||||||||||
Administration: | i.v. or p.o.; single dosage | ||||||||||||
Result: | Pharmacokinetic Parameters of BAY-069 in male Wistar rats[1].
|
References
[1] Günther J, et al. BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. J Med Chem. 2022 Oct 19. DOI:10.1021/acs.jmedchem.2c00441
2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)- Preparation Products And Raw materials
Raw materials
Preparation Products
2,4(1H,3H)-Pyrimidinedione, 3-[4-chloro-3-(2-methylphenoxy)-1-naphthalenyl]-6-(trifluoromethyl)-, (3R)- Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32434 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 52924 | 58 | |
Shanghai Chaolan Chemical Technology Center | 021-QQ:65489617 15618227136 | Sales@ATKchemical.com | China | 9954 | 58 |
Chuzhou KeMail Chemical Technology Co., Ltd | 0550-5196001 15000891977 | wj520wjxby@126.com | China | 1942 | 55 |
Heze Development Zone chuangli Chemical Co., Ltd. | 0530-+86-530-529 6766,+86-15666160102 15666160102 | info@chuangli-chem.com | China | 835 | 55 |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; | sales@rrkchem.com | China | 57422 | 58 |
Guangzhou Younan Technology Co., Ltd | 020-82000279 18988968278 | YN_research@163.com | China | 3003 | 58 |
ShangHai ChuanQian Chemcial Technique Centre | 15869524721 | 3525679403@qq.com | China | 4995 | 58 |
Shanghai Xiushi Biomedical Co., LTD | 15002184385 15021598081 15002184385 | product001@xiushipharm.com | China | 4723 | 58 |
Chunchuang (Wuhan) Technology Co., Ltd | 15727060112 | yutianchun2007@126.com | China | 9802 | 58 |